These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Oral teicoplanin versus oral vancomycin for the treatment of severe Clostridium difficile infection: a prospective observational study. Popovic N, Korac M, Nesic Z, Milosevic B, Urosevic A, Jevtovic D, Mitrovic N, Markovic A, Jordovic J, Katanic N, Barac A, Milosevic I. Eur J Clin Microbiol Infect Dis; 2018 Apr; 37(4):745-754. PubMed ID: 29299697 [Abstract] [Full Text] [Related]
6. Vancomycin Taper and Pulse Regimen With Careful Follow-up for Patients With Recurrent Clostridium difficile Infection. Sirbu BD, Soriano MM, Manzo C, Lum J, Gerding DN, Johnson S. Clin Infect Dis; 2017 Oct 15; 65(8):1396-1399. PubMed ID: 28591789 [Abstract] [Full Text] [Related]
7. Characterization of continued antibacterial therapy after diagnosis of hospital-onset Clostridium difficile infection: implications for antimicrobial stewardship. Harpe SE, Inocencio TJ, Pakyz AL, Oinonen MJ, Polk RE. Pharmacotherapy; 2012 Aug 15; 32(8):744-54. PubMed ID: 23307522 [Abstract] [Full Text] [Related]
8. Comparison of oral vancomycin capsule and solution for treatment of initial episode of severe Clostridium difficile Infection. Bass SN, Lam SW, Bauer SR, Neuner EA. J Pharm Pract; 2015 Apr 15; 28(2):183-8. PubMed ID: 24375999 [Abstract] [Full Text] [Related]
16. An outbreak of Clostridium difficile PCR ribotype 027 in Spain: risk factors for recurrence and a novel treatment strategy. Bouza E, Alcalá L, Marín M, Valerio M, Reigadas E, Muñoz P, González-Del Vecchio M, de Egea V. Eur J Clin Microbiol Infect Dis; 2017 Oct 15; 36(10):1777-1786. PubMed ID: 28501926 [Abstract] [Full Text] [Related]
17. OPT-80 eliminates Clostridium difficile and is sparing of bacteroides species during treatment of C. difficile infection. Louie TJ, Emery J, Krulicki W, Byrne B, Mah M. Antimicrob Agents Chemother; 2009 Jan 15; 53(1):261-3. PubMed ID: 18955523 [Abstract] [Full Text] [Related]